| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| gentamicin | Injection, solution | 80 mg | Resolved | Available | Manufacturing | 20/07/2025 |
| GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Anticipated | Available | Manufacturing | 20/07/2025 |
| GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Anticipated | Available | Manufacturing | 20/07/2025 |
| propranolol hydrochloride | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 18/07/2025 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Anticipated | Available | Manufacturing | 18/07/2025 |
| glimepiride | Tablet, uncoated | 1 mg | Anticipated | Available | Manufacturing | 18/07/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Current | Limited Availability | Manufacturing | 18/07/2025 |
| fentanyl | Drug delivery system, transdermal | 16.8 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 18/07/2025 |
| losartan potassium | Tablet, film coated | 25 mg | Current | Unavailable | Manufacturing | 18/07/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Manufacturing | 18/07/2025 |
| metronidazole | Tablet, uncoated | 400 mg | Current | Limited Availability | Manufacturing | 18/07/2025 |
| risedronate sodium hemipentahydrate | Tablet, film coated | 173.4 mg | Resolved | Available | Manufacturing | 18/07/2025 |
| indapamide hemihydrate | Tablet, sugar coated | 2.5 mg | Anticipated | Available | Manufacturing | 18/07/2025 |
| acarbose | Tablet | 100 mg | Anticipated | Available | Manufacturing | 18/07/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Limited Availability | Unexpected increase in consumer demand | 18/07/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Anticipated | Available | Manufacturing | 18/07/2025 |
| irbesartan | Tablet, film coated | 300 mg | Current | Limited Availability | Manufacturing | 18/07/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Limited Availability | Manufacturing | 18/07/2025 |
| risperidone | Oral Liquid, solution | 1 mg/mL | Current | Limited Availability | Manufacturing | 18/07/2025 |
| Semaglutide | Injection, solution | 1.34 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 18/07/2025 |
| Semaglutide | Injection, solution | 1.34 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 18/07/2025 |
| naloxone hydrochloride dihydrate | Injection | 440 microgram | Anticipated | Available | Unexpected increase in consumer demand | 18/07/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Limited Availability | Manufacturing | 18/07/2025 |
| valsartan~sacubitril | Tablet, film coated | 51.4 mg~48.6 mg | Current | Unavailable | Manufacturing | 18/07/2025 |
| valsartan~sacubitril | Tablet, film coated | 25.7 mg~24.3 mg | Current | Unavailable | Manufacturing | 18/07/2025 |
| sacubitril~valsartan | Tablet, film coated | 97.2 mg~102.8 mg | Current | Unavailable | Manufacturing | 18/07/2025 |
| lanreotide acetate | Injection, solution | 133.33 mg | Current | Limited Availability | Manufacturing | 18/07/2025 |
| Semaglutide | Injection, solution | .68 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 18/07/2025 |
| Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) | Injection, powder for | 200000000 CFU | Current | Limited Availability | Unexpected increase in consumer demand | 18/07/2025 |
| alprostadil | Injection, powder for | 20 microgram/mL | Current | Unavailable | Unexpected increase in consumer demand | 18/07/2025 |
| alprostadil | Injection, powder for | 40 microgram/mL | Current | Unavailable | Manufacturing | 18/07/2025 |
| sertraline hydrochloride | Tablet, film coated | 56 mg | Current | Limited Availability | Manufacturing | 18/07/2025 |
| Epoetin beta | Injection | 6666.66 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Transport / Logistic issues / Storage capacity issues | 17/07/2025 |
| Epoetin beta | Injection | 10000 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Transport / Logistic issues / Storage capacity issues | 17/07/2025 |
| Epoetin beta | Injection | 13333.33 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Transport / Logistic issues / Storage capacity issues | 17/07/2025 |
| Epoetin beta | Injection | 16666.67 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Transport / Logistic issues / Storage capacity issues | 17/07/2025 |
| Epoetin beta | Injection | 20000 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Transport / Logistic issues / Storage capacity issues | 17/07/2025 |
| Epoetin beta | Injection | 16666.67 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 17/07/2025 |
| live varicella vaccine~Measles virus~Rubella virus~Mumps virus | Injection, powder for | 1995 PFU~1000 CCID50~1000 CCID50~25119 CCID50 | Resolved | Available | Manufacturing | 17/07/2025 |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.7 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| tramadol hydrochloride | Capsule | 50 mg | Discontinued | Unavailable | Manufacturing | 17/07/2025 |
| tramadol hydrochloride | Capsule | 50 mg | Anticipated | Available | Manufacturing | 17/07/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 27 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| olanzapine | Tablet, orally disintegrating | 20 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| midazolam | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| sildenafil citrate | Tablet, film coated | 140.45 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 17/07/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 17/07/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 17/07/2025 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| trimethoprim~sulfamethoxazole | Tablet, uncoated | 80 mg~400 mg | Resolved | Available | Manufacturing | 17/07/2025 |
| sulfamethoxazole~trimethoprim | Tablet, uncoated | 800 mg~160 mg | Anticipated | Available | Manufacturing | 17/07/2025 |
| indapamide hemihydrate~perindopril erbumine | Tablet | 1.25 mg~4 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Unexpected increase in consumer demand | 17/07/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Resolved | Available | Manufacturing | 17/07/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 17/07/2025 |
| sumatriptan succinate | Tablet, film coated | 69.99 mg | Anticipated | Available | Manufacturing | 17/07/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 17/07/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Unavailable | Manufacturing | 17/07/2025 |
| ropivacaine hydrochloride | Injection, solution | 150 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 17/07/2025 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 6.94 mg~43.376 mg | Current | Unavailable | Manufacturing | 17/07/2025 |
| phenoxymethylpenicillin potassium | Tablet, film coated | 560 mg | Anticipated | Available | Manufacturing | 17/07/2025 |
| ezetimibe~simvastatin | Tablet | 10 mg~10 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| capecitabine | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in consumer demand | 17/07/2025 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Anticipated | Available | Manufacturing | 17/07/2025 |
| esomeprazole | Capsule, enteric | 20 mg | Current | Unavailable | Manufacturing | 17/07/2025 |
| naproxen | Tablet, modified release | 750 mg | Anticipated | Available | Manufacturing | 17/07/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Unexpected increase in consumer demand | 17/07/2025 |
| solifenacin succinate | Tablet | 10 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| hydrocortisone | Tablet, uncoated | 4 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| deferasirox | Tablet, film coated | 90 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| deferasirox | Tablet, film coated | 360 mg | Anticipated | Available | Manufacturing | 17/07/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.376 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.376 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| flecainide acetate | Tablet | 50 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| chloramphenicol | Eye Drops, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 17/07/2025 |
| paracetamol | Tablet, modified release | 665 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 17/07/2025 |
| dacarbazine | Injection, powder for | 200 mg | Resolved | Available | Manufacturing | 17/07/2025 |
| trandolapril | Capsule, hard | 2 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| labetalol hydrochloride | Tablet, film coated | 100 mg | Anticipated | Available | Manufacturing | 17/07/2025 |
| dalteparin sodium | Injection, solution | 15000 anti-Xa IU | Discontinued | Unavailable | Commercial Changes / Commercial viability | 17/07/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 54 mg | Current | Limited Availability | Manufacturing | 17/07/2025 |
| tranexamic acid | Injection, solution | 1000 mg | Current | Unavailable | Manufacturing | 16/07/2025 |
| ciclesonide | Spray, nasal | 50 microgram/actuation | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 16/07/2025 |
| mycophenolate mofetil | Capsule | 250 mg | Current | Limited Availability | Manufacturing | 16/07/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 16/07/2025 |
| isotretinoin | Capsule, soft | 20 mg | Current | Limited Availability | Manufacturing | 16/07/2025 |
| ropivacaine hydrochloride | Injection, solution | 40 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 16/07/2025 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 10.844 mg~13.88 mg | Current | Limited Availability | Manufacturing | 16/07/2025 |
| midazolam | Injection, solution | 5 mg | Resolved | Available | Manufacturing | 16/07/2025 |
| oxytocin | Injection, solution | 5 IU/mL | Current | Limited Availability | Unexpected increase in consumer demand | 16/07/2025 |
| oxytocin | Injection, solution | 10 IU/mL | Current | Limited Availability | Manufacturing | 16/07/2025 |
| methotrexate | Injection, solution | 100 mg/mL | Resolved | Available | Manufacturing | 16/07/2025 |
| rifampicin | Capsule | 150 mg | Current | Emergency Supply Only | Manufacturing | 16/07/2025 |
| irbesartan~hydrochlorothiazide | Tablet, film coated | 150 mg~12.5 mg | Current | Limited Availability | Manufacturing | 16/07/2025 |
| celecoxib | Capsule, hard | 100 mg | Current | Unavailable | Manufacturing | 16/07/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Limited Availability | Manufacturing | 16/07/2025 |
| phentermine hydrochloride | Tablet, modified release | 18.6375 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/07/2025 |
| phentermine hydrochloride | Tablet, modified release | 37.275 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/07/2025 |
| phentermine hydrochloride | Tablet, modified release | 49.7 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/07/2025 |
| levothyroxine sodium | Tablet, uncoated | .05 mg | Resolved | Available | Manufacturing | 16/07/2025 |
| levothyroxine sodium | Tablet, uncoated | .075 mg | Resolved | Available | Manufacturing | 16/07/2025 |
| avatrombopag maleate | Tablet, film coated | 23.6 mg | Current | Limited Availability | Manufacturing | 16/07/2025 |
| lidocaine hydrochloride | Injection, solution | 20 mg/mL | Resolved | Available | Manufacturing | 16/07/2025 |
| rifabutin | Capsule, hard | 150 mg | Resolved | Available | Manufacturing | 16/07/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 16/07/2025 |
| olanzapine | Injection, powder for | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 16/07/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 16/07/2025 |
| sodium lactate~icodextrin~calcium chloride dihydrate~magnesium chloride hexahydrate~sodium chloride | Solution, dialysis | 4.5 g/L~75 g/L~257 mg/L~51 mg/L~5.4 g/L | Current | Limited Availability | Manufacturing | 16/07/2025 |
| Peginterferon alfa2a | Injection, solution | 135 microgram | Current | Unavailable | Unexpected increase in consumer demand | 16/07/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.96 mg | Current | Unavailable | Manufacturing | 16/07/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Emergency Supply Only | Unexpected increase in demand due to other sponsors unable to supply | 15/07/2025 |
| olanzapine | Tablet, film coated | 5 mg | Resolved | Available | Manufacturing | 15/07/2025 |
| mirtazapine | Tablet, film coated | 45 mg | Current | Unavailable | Manufacturing | 15/07/2025 |
| phenobarbital sodium | Injection, solution | 219 mg/mL | Current | Unavailable | Manufacturing | 15/07/2025 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Current | Unavailable | Manufacturing | 15/07/2025 |
| prucalopride succinate | Tablet, film coated | 2.642 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 15/07/2025 |
| Vespula spp venom | Injection, powder for | 550 microgram | Resolved | Available | Manufacturing | 15/07/2025 |
| bicalutamide~leuprorelin acetate | Injection, modified release~Tablet, film coated | 50 mg~22.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 15/07/2025 |
| bicalutamide~leuprorelin acetate | Injection, modified release~Tablet, film coated | 50 mg~22.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 15/07/2025 |
| hydromorphone hydrochloride | Injection, solution | 2 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 15/07/2025 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 15/07/2025 |
| amiodarone hydrochloride | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 15/07/2025 |
| tamoxifen citrate | Tablet, uncoated | 15.2 mg | Current | Unavailable | Manufacturing | 15/07/2025 |
| tamoxifen citrate | Tablet, uncoated | 30.4 mg | Current | Unavailable | Manufacturing | 15/07/2025 |
| naproxen | Tablet, uncoated | 250 mg | Current | Unavailable | Manufacturing | 15/07/2025 |
| flecainide acetate | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 15/07/2025 |
| betiatide | Injection, powder for | 1 mg | Current | Emergency Supply Only | Manufacturing | 14/07/2025 |
| verapamil hydrochloride | Tablet, modified release | 240 mg | Resolved | Available | Manufacturing | 14/07/2025 |
| fludarabine phosphate | Injection, powder for | 50 mg | Current | Unavailable | Manufacturing | 14/07/2025 |
| honey bee venom | Injection, powder for | 550 microgram | Resolved | Available | Manufacturing | 14/07/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 14/07/2025 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 9.972 mg | Anticipated | Available | Manufacturing | 14/07/2025 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 14/07/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 14/07/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 14/07/2025 |
| candesartan cilexetil | Tablet, uncoated | 32 mg | Resolved | Available | Manufacturing | 14/07/2025 |
| linezolid | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 14/07/2025 |
| solifenacin succinate | Tablet | 5 mg | Resolved | Available | Manufacturing | 14/07/2025 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 14/07/2025 |
| rasagiline mesilate | Tablet | 1.56 mg | Anticipated | Available | Manufacturing | 14/07/2025 |
| ceftazidime pentahydrate~avibactam sodium | Injection, powder for | 2329.7 mg~543.5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 14/07/2025 |
| estradiol~estradiol~norethisterone acetate | Drug delivery system, transdermal | .512 mg~.78 mg~4.8 mg | Resolved | Available | Manufacturing | 14/07/2025 |
| icatibant acetate | Injection, solution | 31.38 mg | Current | Limited Availability | Manufacturing | 14/07/2025 |
| Teriparatide | Injection, solution | 250 microgram/mL | Anticipated | Available | Manufacturing | 14/07/2025 |
| Tiger snake antivenom | Injection, concentrated | 3000 U | Current | Emergency Supply Only | Manufacturing | 14/07/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 14/07/2025 |
2025年7月21日